Therapeutic Augmentation of Ketogenic Diet with a Sodium-Glucose Cotransporter 2 Inhibitor in a Super-Refractory Status Epilepticus Patient

Conclusion SGLT2 inhibitors may have a therapeutic value in SRSE patients who cannot achieve ketosis with KD alone.

Source: Epilepsy and Behavior Case Reports - June 20, 2018 Category: Neurology Source Type: research